To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize manufacturing schedules and resources. In battling the COVID-19 pandemic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback